Media coverage
1
Media coverage
Title Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303 Media name/outlet Spoke.com Country/Territory United States Date 17/12/18 URL www.spoke.com/press_releases/5c175f902cf3f7f6cb03bec2 Persons Jeremiah Faith